For the first time, WHO offers recommendations for national health authorities, regulators, and funders to improve clinical trials.
The guidance addresses issues like poor trial design, lack of diversity and inclusion of at-risk populations, infrastructure gaps, and inefficiencies that delay progress.
https://t.co/hyMo975Wsh
PSI's Pandemic PACT programme has launched a vital resource for tracking and understanding research on new or re-emerging global health threats, including #mpox and #H5N1.
Visit the Pandemic PACT website to learn more 👇
https://t.co/qKQj89sbGw
Why do we keep telling ourselves we need to “learn the lessons” of outbreaks? There have been many outbreaks, surely we should have learned by now? We either have collective amnesia or collective narcolepsy argues Ros Upshur from University of Toronto. #PandemicSciences2024
Important point by @mlipsitch at #PandemicSciences24: the success of the 100 days mission for vaccine development during a pandemic depends on success of non-pharmaceutical interventions before vaccines become available.
Congratulations to @GloPID_R's Research & Policy team who are finalists in the @UniofOxford Vice-Chancellor’s Awards 🎉
The team was nominated for outstanding research engagement on a roadmap for funders to improve clinical trial coordination.
More 👇
https://t.co/nzjuvXgdXr
🚨Funding opportunity for #mpox !
In the light of rising numbers of cases in #DRCongo & the high public health risk we are activating a €5 million emergency mechanism to support research into #vaccines, #treatments and #diagnostics 🔬💉
Find out more ➡️https://t.co/X8fissboBS
🚨 NEW REPORT: Patients face “new normal” of #MedicinesShortages as UK hampered by supply issues and impact of EU exit.
Read our thread. 👇https://t.co/DjCbSvhR5b
Good news for climate action! A group of Swiss 🇨🇭 women have won the first ever climate case victory in the European Court of Human Rights.
https://t.co/XGmvbUwi03
Pandemic PACT, a new tool to track global funding for #PandemicResearch, was launched by @PSIOxford in collaboration with @GloPID_R and @UKCDR. The initiative will improve the global research response to #InfectiousDisease outbreaks 🤝🦠👨🔬
Read more 👉 https://t.co/e8FGL8ikeT
Thank you to everyone who joined yesterday's Pandemic PACT launch, hosted with @GloPID_R & @UKCDR.
The new tool will:
✅ support funders to channel resources where they are needed most
✅ strengthen global #pandemic preparedness.
Read the full story 👇
https://t.co/UXaHLpEmWC
Together with @GloPID_R, today we’ve launched Pandemic PACT, a new tool to track global funding for pandemic research.
🔗 Explore the tool:
https://t.co/dBzTX2PD51
➡️ Find out how Pandemic PACT is supporting pandemic preparedness via @TheLancet:
https://t.co/VNjDKJ1GWs
A potential vaccine candidate for tuberculosis, supported by Wellcome and @gatesfoundation, has started its Phase 3 clinical trial in South Africa.
If shown to be well-tolerated and effective, the vaccine could become the first tuberculosis vaccine in over a century.
This decision by @NICEComms is utterly wrong and is likely to deny a life-saving treatment for people with SOD1 #ALS#MND that is already approved in Europe and the US. A terrible, wrong-headed decision that must be changed.
@DHSCgovuk@mndassoc@MNDoddie5@MNDScotland
El futuro acuerdo sobre la pandemia debe garantizar que los productos sanitarios de la I+D financiada con fondos públicos sean accesibles de manera equitativa.
Mi columna en @el_pais@Planeta_Futuro: https://t.co/vieLMHSP66
#INB8#PandemicAccord